NCT04211688View on ClinicalTrials.gov

Effectiveness of a Combined Group-individual Schema Therapy for Borderline Personality Disorder

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 12, 2017

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Borderline Personality DisorderRandomized Controlled Trial
Interventions
BEHAVIORAL

Group Schema therapy

Bimonthly outpatient psychotherapy delivered in individual setting

BEHAVIORAL

Individual Schema therapy

weekly outpatient psychotherapy delivered in group setting

All Listed Sponsors
collaborator

Department of Health, Generalitat de Catalunya

OTHER_GOV

lead

Consorci Sanitari del Maresme

OTHER

NCT04211688 - Effectiveness of a Combined Group-individual Schema Therapy for Borderline Personality Disorder | Biotech Hunter | Biotech Hunter